A panelist discusses how clinicians should systematically adopt evidence-based hidradenitis suppurativa (HS) guidelines while maintaining flexibility to tailor treatments to individual patient needs, ...

Panelist discusses how hidradenitis suppurativa’s early detection is challenging due to misdiagnosis, patient stigma, and limited awareness. Improved physician education, proactive screening, and ...

For patients with hidradenitis suppurativa in this study, antibiotics were prescribed in 74.7% of ED visits, compared to 49.0% of ambulatory visits. The current study found low usage (9.9%) of ...

One biologic, adalimumab, is currently approved to treat hidradenitis suppurativa. Adalimumab works by targeting a specific inflammation pathway involved in the condition. Hidradenitis suppurativa (HS ...

Hidradenitis suppurativa (HS)is a skin condition that causes painful lesions in blocked hair follicles. HS mostly occurs on body parts that come into contact with each other, including the inner ...